“Drugs” are both narcotics and medicines
Read and expand your awareness: Two new books deal with all kinds of “Drugs”: “Coffee Poppy Cactus” by Michael Pollan and “Yoga, Tea, LSD” by Andrea Jungaberle
DO PSYCHEDELICS REALLY HAVE THE POWER TO DISRUPT HEALTHCARE? IF SO, HOW?
The Psychedelics as Medicine Report: Third Edition (2021) is an industry report outlet. It describes itself as “a premium business-to-business media and content platform for the psychedelic science and healthcare industry. Part of Psych Capital Plc.”. As such it tries to collect “consumer insights and market intelligence from experts and industry leaders, helping investors cut through the noise and identify real opportunities.”
Dr. Henrik Jungaberle has been interviewed for the report by Floris Wolswijk. Henrik is not involved with and has not been paid for the interview by either of the parties who produced or sponsored the report. His views are his own.
Pharmacologically based long-term therapies are often the treatment of choice for depression. Augmented psychotherapy, which uses mind-altering substances such as ketamine, is a new approach to helping depressed people. The altered states of consciousness induced in this way are then therapeutically integrated This treatment method, which is still relatively new in Germany, is the focus of Dr. med. Andrea Jungaberle and her colleagues in their clinic in Berlin Friedrichshain. Esanum visited the interdisciplinary team and informed us about the innovative procedure.
The esanum physician network has made a video report about the newly opened OVID Clinic Berlin. In it, Andrea Jungaberle, MD, Sergio Pérez and members of the team of therapists present the concept for psychedelic-augmented psychotherapy. Augmented means “amplified, expanded, intensified”.
At INSIGHT 2021, scientists and therapists, pharmaceutical industry and anthropology, philosophers, and chemists will come together to determine the potential place of LSD, psilocybin, DMT, MDMA, and other psychedelic substances in the treatment of mental disorders. In addition, we will discuss the use of non-pharmacological methods to alter and cultivate states of consciousness and all that it takes to build such unusual states of consciousness a legitimate and safe place in society.
German journalist Marlene Halser on the LSD-researcher Hanscarl Leuner
“Psychedelic mushrooms are in demand on the stock market – this man paved the way for them” (Wirtschaftswoche)
For almost 30 years, Hanscarl Leuner treated people with LSD and psilocybin at the University Hospital in Göttingen. Substances in which highly valued start-ups are currently investing – while the German researcher has been relegated to the sidelines of society.”
… and a free link to “The History of Psychedelics in Psychiatry”
Pharmacologically based long-term therapies are often the treatment of choice for depression. Augmented psychotherapy, which uses mind-altering substances such as ketamine, is a new approach to helping depressed people. The altered states of consciousness induced in this way are then therapeutically integrated This treatment method, which is still relatively new in Germany, is the focus of Dr. med. Andrea Jungaberle and her colleagues in their clinic in Berlin Friedrichshain. Esanum visited the interdisciplinary team and informed us about the innovative procedure.
The esanum physician network has made a video report about the newly opened OVID Clinic Berlin. In it, Andrea Jungaberle, MD, Sergio Pérez and members of the team of therapists present the concept for psychedelic-augmented psychotherapy. Augmented means “amplified, expanded, intensified”.
“For anyone who wants to get a differentiated picture”.
Alcohol, coke, pills – the list of available drugs is long, and so is the list of addictions. “Being High” is a handbook that casts a nuanced picture on drugs of all kinds. “We have a very dysfunctional relationship with the people who use them,” author Henrik Jungaberle told Dlf.
Henrik Jungaberle in a Corso conversation with Ulrich Biermann
Berlin’s MIND Foundation is one of Europe’s largest psychedelic therapy organizations with global aspirations. MIND has a range of amazing programs for therapists, academics, and anyone else interested in new psychedelic therapies. In this episode we discuss a range of issues including European psychedelic landscape, ethics of Psychedelic-Assisted Therapies, cultural issues, issues of growth, and many other issues related to healing with psychedelics.
Gert Scobel discusses new therapies with hallucinogenic drugs with historian Magaly Tornay, psychiatrist Franz Vollenweider, and philosopher and neuroethicist Thomas Metzinger.
The #drucscience2017-conference presented speakers from medicine, psychotherapy, neurosciences, pharmacology, public health and anthropology to discuss the state of the art in drug science.